Insulin Glargine (U-100) Cartridge Systems and Pens and Juxtapid Capsules
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and Juxtapid Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: lomitapide
Brand name: Juxtapid
Synonyms: Lomitapide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Jynarque
- Juxtapid Capsules-Insulin Glargine (U-100) Vials
- Juxtapid Capsules-Insulin Glargine (U-300) Pens
- Juxtapid Capsules-Insulin glargine and lixisenatide
- Juxtapid Capsules-Insulin glargine and lixisenatide Subcutaneous
- Juxtapid Capsules-Insulin glargine, recombinant Subcutaneous
- Juxtapid Capsules-Insulin glulisine